Literature DB >> 2042059

Epidemiology and etiology of ovarian cancer.

M S Piver1, T R Baker, M Piedmonte, A M Sandecki.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 2042059

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  14 in total

1.  Genetic predisposition to ovarian cancer.

Authors:  J L Freddo
Journal:  West J Med       Date:  1992-06

2.  Fertility drugs and ovarian epithelial cancer: is there a link?

Authors:  R J Paulson
Journal:  J Assist Reprod Genet       Date:  1996-11       Impact factor: 3.412

3.  Distribution of radiolabelled anti-CA125 monoclonal antibody OC125-F(ab)2-fragment following resection guided by antibodies (REGAJ) in ovarian cancer patients.

Authors:  M M Uttenreuther-Fischer; H Feistel; F Wolf; W Jäger
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

4.  Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas.

Authors:  K Kurose; X P Zhou; T Araki; S A Cannistra; E R Maher; C Eng
Journal:  Am J Pathol       Date:  2001-06       Impact factor: 4.307

5.  Cellular distribution of retinoic acid receptor-alpha protein in serous adenocarcinomas of ovarian, tubal, and peritoneal origin: comparison with estrogen receptor status.

Authors:  C D Katsetos; I Stadnicka; J C Boyd; H Ehya; S Zheng; C M Soprano; H S Cooper; A S Patchefsky; D R Soprano; K J Soprano
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

6.  Clinicopathological significance of WT1 expression in ovarian cancer: a possible accelerator of tumor progression in serous adenocarcinoma.

Authors:  Sohei Yamamoto; Hitoshi Tsuda; Tsunekazu Kita; Kazunari Maekawa; Kazuyuki Fujii; Kazuya Kudoh; Kenichi Furuya; Seiichi Tamai; Johji Inazawa; Osamu Matsubara
Journal:  Virchows Arch       Date:  2007-06-27       Impact factor: 4.064

Review 7.  Calcium-sensing receptor in cancer: good cop or bad cop?

Authors:  Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

8.  Sustained platelet-sparing effect of weekly low dose paclitaxel allows effective, tolerable delivery of extended dose dense weekly carboplatin in platinum resistant/refractory epithelial ovarian cancer.

Authors:  Rohini Sharma; Janet Graham; Sarah Blagden; Hani Gabra
Journal:  BMC Cancer       Date:  2011-07-11       Impact factor: 4.430

9.  Extended weekly dose-dense paclitaxel/carboplatin is feasible and active in heavily pre-treated platinum-resistant recurrent ovarian cancer.

Authors:  R Sharma; J Graham; H Mitchell; A Brooks; S Blagden; H Gabra
Journal:  Br J Cancer       Date:  2009-02-17       Impact factor: 7.640

10.  Wilms' tumor 1 (WT1) promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling.

Authors:  Yun Han; Chao Song; Tingting Zhang; Qianqian Zhou; Xiaoqian Zhang; Jing Wang; Boqun Xu; Xuesen Zhang; Xiaoqiu Liu; Xiaoyan Ying
Journal:  Cell Cycle       Date:  2020-09-07       Impact factor: 4.534
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.